Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.
Just another article about how the UK Government have not met their daily testing quota of 200,000 tests a day (struggling to consistently achieve 100,000 a day).
https://www.independent.co.uk/news/health/coronavirus-uk-tests-how-many-daily-number-figure-chart-a9503356.html
There is a map in the above article which also shows the % of the population that has been tested so far. I'm not saying every single person has to be tested but when you see the 2% for UK it does show testing testing is far from over anywhere and plenty of room for GDR to secure orders globally. Using a different website's numbers I believe for e.g. India have only tested 0.2% of their 1.3billion population, just one of so many countries far behind with their testing.
Honestly, I'm happy just for the forthcoming PR, increased profile is worth alot in itself...anything else (RNS, sales etc) a brucie bonus.
Just keeping my own expectations in check (for now at least but might lose the plot tomorrow and go on a rampage lol).
GLA
Talking of PR, they should have tweeted this as well, honestly wouldn't have known if not posted on here (I don't have linked in)
GLA.
Following PR tomorrow & Friday, how cool is it that Monday is the first of June.
I know they didn't say sales 1st of June they said "aims to record first commercial sales in June." so anytime between 1st and 30th June but who would want to be out of this knowing sales RNS could drop anyway, the excitement and anticipation.
GLA
Proactive Investors (Thursday), SKY News and Share Talk (Friday).
I know it's Wednesday today but can I be the first to say, "I wouldn't want to be out of this over the weekend" LMAO.
GLA
Thanks to all for sharing the linkedin post and news and to all that contacted various media outlets about what we have going on, things are going to get mighty interesting.
GLA
So people are looking for as low as 120-130 if you get that well done, but I would not be surprised if you don't even get 140 again.
MM's release the brakes.
Placing tomorrow, so a rise this afternoon into the close would not surprise me as they can't hold that over us tomorrow.
GLA
Fear Of Going Lower, will be flipped to Fear of Missing Out in a flick of a switch by the MM when they want to release the brakes and then watch this rise...GLA.
Touched £3 before placing on 5th May.
Now half that price and have since achieved a CE product!
GLA
IMHO expecting today to be the last day to pick up shares cheaper, with most having already been forward sold, tomorrow this placing cloud over us will be removed, and so quite feasible we get a decent rise tomorrow to people's surprise.
What now/next (from 22 May RNS)....
"the Company can commence commercial sales in the UK and across the EU immediately. The Company will now begin distribution to potential customers for initial clinical evaluations, and aims to record first commercial sales in June."
"CE marking was achieved with performance studies and validations that will also support regulatory applications in other jurisdictions, such as Emergency Use Authorisation with the USA FDA and Emergency Use Assessment and Listing with the WHO. "
I don't believe the above is already priced in.
DYOR and GLA
A reminder that testing is not over even as countries reopen, accurate testing is one of the most important tools in states' arsenals to track — and stop — the spread of the coronavirus.
So testing, rather accurate testing is required, enter GDR 100% sensitivity and 98.2% specificity,
placing it in a top tier performance table for COVID-19 PCR tests.
GLA
Looks like the 75K shares sell @145.5p was what MMs were squeezing out, now move it back up and sell it on for a nice profit.
On the 20th April they announced the product would be ready in the next 5 weeks and then on 1st May they announced CE marking in approx 3 weeks time.
Massive ticks for achieving the above.
Bodes well and great confidence when on 24th May they use the word IMMEDIATELY commence sales and JUNE (they didn't mention a specific date but not long before the month starts at least) to record sales.
" the Company can commence commercial sales in the UK and across the EU immediately. The Company will now begin distribution to potential customers for initial clinical evaluations, and aims to record first commercial sales in June."
A reminder what Cytiva had to say last month.
"Gabriel Fernandez de Pierola, General Manager, Genomics and Diagnostics at Cytiva, says: "The spread of the SARS-COV-2 virus is driving an urgent need for extensive testing, particularly amongst patients and health workers. Critical to overcoming the pandemic is being able to produce high volumes of reliable tests which can be shipped easily on a global basis with minimal environmental impact. We hope our Lyo-Stable technology coupled with Genedrive's high throughput testing solution will help deliver technical solutions to address the current crisis."
Did we do what was critical? heck yes...
Reliable test, achieved 100% sensitivity and 98.2% specificity, placing it in a top tier performance table for COVID-19 PCR tests, big tick.
High volumes, well we can do over 10,000/hr and are kicking off with producing 6M, get the orders for more, heck we have capacity to produce more tick.
Shipped easily on a global basis, well our Genedrive® 96 SARS-CoV-2 kit is stable at ambient temperatures which eliminates the need for cold storage, making the test very practical for global export markets.
So well done partner.
Now let's get them orders announced so GDR can Pass GO and collect 200 (that's £200 Million market cap i hope lol.)
UB
GL to us all.
Are you here for the Covid stock play? Well be prepared to be pleasantly surprised when you see what else GDR have going on, far from a one-trick pony.
Also, some additional reading (Sorry if posted before and apologies it's from earlier this month also, but as newbie to GDR may help others) by Vanya
https://www.thearmchairtrader.com/genedrive-lse-gdr-stock-rally-has-legs/
That's all from me folks, happy bank holiday!
It's important to read through the past RNS before investing in any share (DYOR comes to mind and of course not only RNS).
Thanks to those who guided me especially to the proposed placing RNS 5th May, that is filled to the brim with information which you must read through thoroughly. Why, because honestly I missed about 3/4 Of it, I thought I had read the whole RNS and that it ended when it provided the contact details in the table, boy was I pleasantly surprised when I browsed further below and saw so much more relevant information. I'm sure you are not as silly as me and have read it all to the very end, but just in case well worth a revisit as it will certainly give you some valuable summary and further insight into the company. I certainly felt more at ease when I read it all.
GLA
"On 20 April 2020, genedrive announced that it had entered into a development agreement with Cytiva (formerly GE Healthcare Life Sciences) to allow for high throughput manufacturing of over 10,000 tests per hour. genedrive has also secured sufficient supply chain commitments for the most critical components to enable the manufacturing of six million tests. The Company anticipates launching the Genedrive® 96-SARS-CoV-2 in May 2020 at an estimated price of £8-10 per test. The Company will address the market on a non-exclusive basis with sales through an appropriate mix of distributors and direct to customers. The Directors believe that based on its sales volume forecasts and estimates of selling prices in the market, the Company will be able to achieve attractive gross margins of at least 60%, noting genedrive does not fully absorb labour costs into its margins."
Sell between £8 And £10 per test
Profit at least 60% so at least £4.80 - £6
So for easy numbers let's say profit of £5 per test
Manufacture and sell the 6M tests....that's £30M profit right there!
Have a great long weekend.